Hypoxanthine in Deoxyribonucleic Acid: Generation by Heat-induced Hydrolysis of Adenine Residues and Release in Free Form by a Deoxyribonucleic Acid Glycosylase from Calf Thymus
Overview
Affiliations
A slow conversion of adenine residues to hypoxanthine occurs in single-stranded DNA when heated in neutral aqueous buffers. The rate of this reaction at pH 7.6 and 110 degrees C is k = 4 x 10(-8) s-1, as determined by base analysis of heat-treated DNA that contains radioactively labeled adenine residues. It is proposed that adenine deamination is one of several forms of hydrolytic damage that may occur as spontaneous premutagenic lesions in DNA in vivo. Cell extracts from calf thymus and human fibroblasts contain a DNA glycosylase activity with specifically catalyzes the release of free hypoxanthine from DNA or polydeoxyribonucleotides that contain dIMP residues. Several properties of the purified enzyme from calf thymus are described: It has an approximate molecular weight of 31 000. No cofactors are required for activity. The enzymatic release of hypoxanthine occurs readily from double-stranded polydeoxyribonucleotides that have either thymine or cytosine residues in the complementary strand. Single-stranded polymers are 10-20-fold more slowly attacked, and there is no detectable cleavage of monomeric dIMP. Hypoxanthine is liberated from DNA directly as a free base. Thus, when poly(dI) x poly(dC) containing both [3H]-dIMP and [32P]dIMP residues was employed as the substrate, 3H-labeled hypoxanthine but no 32P-labeled material was released in ethanol-soluble form. The hypoxanthine-DNA glycosylase presumably acts in DNA repair by preventing deaminated adenine residues from being expressed as mu.
Iliushchenko D, Efimenko B, Mikhailova A, Shamanskiy V, Saparbaev M, Matkarimov B Mol Biol Evol. 2025; 42(2).
PMID: 39903101 PMC: 11792237. DOI: 10.1093/molbev/msae261.
Davletgildeeva A, Kuznetsova A, Ishchenko A, Saparbaev M, Kuznetsov N Int J Mol Sci. 2024; 25(16).
PMID: 39201583 PMC: 11354406. DOI: 10.3390/ijms25168897.
Major L, McClements M, MacLaren R Int J Mol Sci. 2023; 24(8).
PMID: 37108761 PMC: 10146473. DOI: 10.3390/ijms24087603.
Considerations for the Terminal Sterilization of Oligonucleotide Drug Products.
DeCollibus D, Searcy J, Tivesten A, Akhtar N, Lindenberg C, Abarrou N Nucleic Acid Ther. 2023; 33(3):159-177.
PMID: 36787481 PMC: 10277985. DOI: 10.1089/nat.2022.0073.
Mammalian N1-adenosine PARylation is a reversible DNA modification.
Musheev M, Schomacher L, Basu A, Han D, Krebs L, Scholz C Nat Commun. 2022; 13(1):6138.
PMID: 36253381 PMC: 9576699. DOI: 10.1038/s41467-022-33731-w.